Loading...
Potential strategies against resistance to CAR T-cell therapy in haematological malignancies
Chimeric antigen receptor (CAR) T-cell therapy is a rapidly developing method for adoptive immunotherapy of tumours in recent years. CAR T-cell therapies have demonstrated unprecedented efficacy in the treatment of patients with haematological malignancies. A 90% complete response (CR) rate has been...
Saved in:
| Published in: | Ther Adv Med Oncol |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
SAGE Publications
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7576929/ https://ncbi.nlm.nih.gov/pubmed/33133242 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835920962963 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|